Search research articles
Contact Us
Filters
Showing results (521-530 of 581) with videos related to
Page
of 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
Gopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
European Urology Focus
|
December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course
Renzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
The Journal of Clinical Investigation
|
June 9, 2007
Improved prediction of prostate cancer recurrence through systems pathology
Carlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
The American Journal of Surgical Pathology
|
October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations
Sounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Mayo Clinic Proceedings
|
June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors
Sounak Gupta, Paige Nichols, Christine M Lohse, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 15, 2021
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma
Xiao-Ming Wang, Yuping Zhang, Rahul Mannan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)
Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Page
of 59
Search research articles
Search
Showing results (521-530 of 581) with videos related to
Sort By:
Page
of 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
Gopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
European Urology Focus
|
December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course
Renzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
The Journal of Clinical Investigation
|
June 9, 2007
Improved prediction of prostate cancer recurrence through systems pathology
Carlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
The American Journal of Surgical Pathology
|
October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations
Sounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Mayo Clinic Proceedings
|
June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors
Sounak Gupta, Paige Nichols, Christine M Lohse, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 15, 2021
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma
Xiao-Ming Wang, Yuping Zhang, Rahul Mannan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)
Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Page
of 59